Epilepsy Foundation’s 2016 Pipeline Conference Will Promote Advancement of Drugs, Research, and Technology for 3 Million in U.S. Living with Seizures

Event includes “Shark Tank” competition introducing innovative ideas around epilepsy treatment for prizes totaling $200,000
Thursday, February 18, 2016

San Francisco, CA - The 2016 Epilepsy Foundation Pipeline Conference will be held on February 25 to 26, 2016, in San Francisco, California. Attendees will be introduced to new epilepsy treatments, therapeutic innovations, and product developments. The conference will also include the 5th annual “Shark Tank” competition that will highlight new ideas in epilepsy treatment and therapies.

The Epilepsy Foundation Pipeline Conference brings together key decision-makers within the epilepsy community. Speakers and attendees will include emerging biotech and medical technology companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy treatment advances. Presenting companies and organizations were hand-chosen by the Epilepsy Foundation’s Professional, Scientific, and Business Advisory Boards.

“The pipeline meeting is an opportunity for the community to get a preview of exciting new therapies and devices that are under development,” said Jacqueline French, MD, chief scientific officer of the Epilepsy Foundation and professor of neurology at New York University. “This year, many of the drugs being presented address orphan diseases that currently have no effective therapies. We are excited to hear about the progress of these therapies towards the clinic.”

The conference will feature the “Shark Tank” competition with special celebrity guest shark Rick Harrison (“Pawn Stars”). The competition will have inventors introduce key innovative ideas in epilepsy treatment for prizes totaling $200,000. In addition to the sharks awarding prizes, the attending audience will also have the opportunity to give part of the award money toward ideas that will improve the quality of life of people with epilepsy.

The Pipeline Conference will be held at the Grand Hyatt in San Francisco, California.

Thank you to our sponsors: UCB, Lundbeck, and Eisai Co.


About Epilepsy

When a person has one or more unprovoked seizures, they are considered to have epilepsy. Epilepsy affects 3 million people in the U.S. and 65 million worldwide. This year, another 150,000 people will be diagnosed with epilepsy. Despite all available treatments, 4 out of 10 people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.

About the Pipeline Conference

The Epilepsy Foundation Pipeline Conference launched in 2008 as part of the Epilepsy Therapy Project, and has been held every other year since its inception. The purpose of the conference is to survey new therapies in development, explore future advances and encourage collaborations and partnership. For additional information, please visit www.epilepsy.com.

About the Epilepsy Foundation

The Epilepsy Foundation, a national non-profit with nearly 50 local organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is to stop seizures and sudden unexpected death in epilepsy (SUDEP), find a cure, and overcome the challenges created by epilepsy through efforts including education, advocacy, and research to accelerate ideas into therapies. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. For additional information, please visit www.epilepsy.com.

“Like” the Epilepsy Foundation on Facebook at facebook.com/epilepsyfoundationofamerica and follow us on Twitter at twitter.com/epilepsyfdn.

Contact Name: 
LeAnn Harley | Manager of Program Communications and Media Relations
Contact Phone: 
(301) 918-3721
Contact Email: 

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

24/7 helpline